87 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
affect the interests of the CVR Holders; or
(v) any other amendments hereto for the purpose of adding, eliminating or changing any provisions … hereto for the purpose of adding, eliminating or changing any provisions of this Agreement, even if such addition, elimination or change is adverse
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
subsidiary of SNBL established for the purpose of the Tender Offer in the State of Delaware, United States. The Tender Offer period expired at 12:00 A.M
8-K
EX-3.1
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
.
ARTICLE III
The purpose of the Company is to engage in any lawful act or activity for which corporations may be organized under the Delaware
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting … or exchange of stock, or for the purpose of any other lawful action, the Board may fix a record date, which record date shall not precede the date
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
30 May 23
Tender offer solicitation (amended)
9:42pm
. After further discussion, taking into account the factors described under “Purpose and Reasons of the Company for the Offer and Merger; Recommendation
SC 14D9/A
y5htnqqhmh910n
24 May 23
Tender offer solicitation (amended)
9:40pm
CORRESP
kyorxdpofte tsd
24 May 23
Correspondence with SEC
12:00am
UPLOAD
b1zjykhji7v1bvkomwy3
23 May 23
Letter from SEC
12:00am
SC 14D9
owha8h rdf
5 May 23
Tender offer solicitation
8:17am
10-K/A
fl1 o4w0sblq3zs2tc
28 Apr 23
Annual report (amended)
4:08pm
8-K
EX-2.1
8yxdnpnmydv157c91il
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-10.1
4wnhvq0m
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
20uzi
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.2
sun8wszglbljubjiew
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
SC TO-C
EX-99.2
0lh 92rkj8egr
17 Apr 23
Information about tender offer
6:08am
8-K
EX-1.1
lazfp
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
4dnpa5 4lenwpokro
3 Nov 22
Prospectus supplement for primary offering
4:42pm